Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: PF.04691502

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
PF.04691502 PF4691502 PI3K, mTOR PI3K-AKT-mTOR signaling Phase 1, 2 Selleck Chemicals S2743

Cell Line (34)
Cell LineAUCGI50
Li70.440.195
SNU8860.530.135
JHH40.540.11
HCC.1.20.570.175
SNU8780.580.165
JHH10.580.16
PLC.PRF50.60.195
B10.60.164
Huh70.60.177
Hep3B0.60.42
HCC.30.610.165
SNU3980.620.29
HCC.1.10.630.375
HepaRG0.630.325
SNU4230.650.41


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it